Evidence map›Paper›PMID 40226730›Full record

SynthesisDepression and anxiety2024

Prevalence and Predictors of Nonresponse to Psychological Treatment for PTSD: A Meta-Analysis.

Verena Semmlinger, Cosima Leithner, Lea Maria Klöck, Lena Ranftl, Thomas Ehring, Monika Schreckenbach

Abstract readMeta-Analysis
In one paragraph

Synthesis in Depression and anxiety, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Treatment of posttraumatic stress disorder (PTSD).Dialogues in clinical neuroscience · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Verena SemmlingerDepartment of Psychology, Ludwig-Maximilians-University Munich, Munich 80802, Germany.ORCID 0000-0001-9201-7464
Cosima LeithnerDepartment of Psychology, Ludwig-Maximilians-University Munich, Munich 80802, Germany.ORCID 0009-0005-8130-6793
Lea Maria KlöckDepartment of Psychology, Ludwig-Maximilians-University Munich, Munich 80802, Germany.ORCID 0009-0004-2480-7404
Lena RanftlDepartment of Psychology, Ludwig-Maximilians-University Munich, Munich 80802, Germany.ORCID 0009-0000-0929-201X
Thomas EhringDepartment of Psychology, Ludwig-Maximilians-University Munich, Munich 80802, Germany.ORCID 0000-0001-9502-6868
Monika SchreckenbachDepartment of Psychology, Ludwig-Maximilians-University Munich, Munich 80802, Germany.ORCID 0009-0005-8019-2018

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Although highly efficacious psychological treatments for posttraumatic stress disorder (PTSD) exist, there is evidence that first-line psychological treatment approaches leave a substantial subgroup of patients still suffering from clinically relevant PTSD symptoms posttreatment. Aims: We aimed to meta-analytically establish the prevalence and predictors of nonresponse to first-line guideline-recommended psychological treatments for PTSD. Materials and Methods: This meta-analysis was preregistered (CRD42023368766). We searched the PTSD Trials Standardized Data Repository, Embase, Medline, PsychINFO, and PTSDpubs. We included randomized controlled trials (RCT), reporting data on nonresponse operationalized by (lack of) symptom reduction in PTSD symptoms at posttreatment of first-line guideline-recommended PTSD treatments for adult patients meeting criteria for a PTSD diagnosis. All studies published by October 10, 2023, were included. Data were extracted by two independent reviewers. We estimated the pooled average nonresponse rates and ORs. Subgroup and metaregression analyses targeting the nonresponse rates served to identify significant predictors. All analyses were conducted using three-level multilevel models. Study quality was assessed using Cochrane's RoB 2 tool. Results: Eighty six studies with 117 active treatment conditions and 7,894 participants were included in the meta-analysis. The weighted average nonresponse rate was 39.23%, 95% CI (35.08%, 43.53%). Nonresponse was less frequent in the treatment condition compared to the control condition ( Conclusions: This meta-analysis found that a substantial subgroup of patients suffering from PTSD still showed clinically significant symptoms after having received treatment. Treatment modifications should be considered for specific subgroups of PTSD patients based on predictors found to be associated with nonresponse.

Indexed as

PsychotherapyStress Disorders, Post-TraumaticHumansPrevalenceRandomized Controlled Trials as Topic

Identifiers

PMID40226730
PMCPMC11918500

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.